Categories Analysis, Industrials

General Motors (GM) fast-tracks EV transition. Is the stock a buy?

The strong cash flow allows GM to invest heavily in growth initiatives, currently focused on the EV business

General Motors Co. (NYSE: GM) has been ramping up its electric vehicle business, rolling out new models and expanding the production of battery packs. The auto giant’s aggressive EV strategy has started translating into profit, a trend that is expected to drive growth in the long term.

GM’s stock made strong gains in the past two weeks and is currently trading at a two-year high. The value nearly doubled in the past six months, and the positive investor sentiment is expected to hold in the coming months. The underlying strength of GM’s legacy business, combined with the emerging EV portfolio, should allow the company to maintain its dominance in the market. For investors, it would be a good idea to add the stock to their watchlists.

EV Shift

The GM leadership is bullish about the growing EV portfolio, mainly the Chevrolet Equinox which is touted as the most affordable car in the segment and purpose-built electric pickups Chevrolet Silverado EV RST and GMC Sierra EV Denali. It is making heavy investments in the EV business in the pursuit of an all-electric future. Meanwhile, there are concerns that the company is probably setting the bar too high considering the recent slowdown in the EV market. There has been a dip in the demand for purely electric vehicles as customers increasingly opt for gasoline-electric hybrid vehicles.

“We continue to see sequential and year-over-year improvements in variable profit and EBIT margins as we benefit from scale, material cost, and mix improvements. Since last year, we have significantly reduced cell costs with a large driver being lower battery raw material costs, especially for lithium. We ramped up our first battery JV plant last year. And as they increased production and made other efficiencies, the cost of cells came down significantly. And cell plant number two in Tennessee is ramping even faster based on the learnings from plant one and is expected to reach full Installed capacity by the end of the year.” GM’s CEO Mary Barra said during a recent interaction with analysts.

GM this week announced a new authorization for repurchasing up to $6 billion of the outstanding stock, as part of its strategy of creating shareholder value consistently. The company has been maintaining healthy cash flows, reflecting strong revenue growth and margin performance, which is good considering the heavy capital spending related to capacity expansion and new vehicle launches.

Q1 Numbers Beat

For the first three months of fiscal 2024, General Motors reported a 7.6% increase in revenues to $43 billion, mainly reflecting a 9% sales growth in the core GM North America segment. That was partially offset by a 16% drop in international sales. The results far exceeded Wall Street’s projections. Taking a cue from the upbeat performance, the management raised its EBIT guidance for fiscal 2024 to $12.5-14.5 billion. Full-year earnings per share guidance was revised to $9-10 from the earlier outlook of $8.5-9.5.

GM’s stock traded up 1.4% on Tuesday afternoon, after closing the previous session lower. It has traded above the 52-week average in recent months.

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

FDX Earnings: FedEx Corporation reports higher Q4 revenue and adj. profit

Cargo giant FedEx Corporation (NYSE: FDX) Tuesday reported an increase in revenues and adjusted earnings for the fourth quarter of 2024. The positive top-line performance reflects revenue growth in the

Alumis looks to raise $300 million in IPO. Here’s what you need to know

Technology and healthcare companies are continuing to dominate the IPO market, which is witnessing a significant increase in activity compared to 2023. Alumis Inc., a clinical-stage biopharmaceutical company that develops

CCL Earnings: Carnival Corp. swings to profit in Q2 on strong revenue growth

Carnival Corporation & plc. (NYSE: CCL) on Tuesday posted strong revenue growth for the second quarter of 2024. The cruise line operator reported a profit for Q2, compared to a

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top